The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -35.97%. However, over the past six months, we’ve seen a stronger performance of -51.89%. The price of VIR leaped by -15.01% over the last 30 days. And in the last five days, it has fallen by -16.52%.
The market performance of Vir Biotechnology Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $14.45 on 01/08/25, while the lowest value for the same duration was $4.95 on 05/13/25.
52-week price history of VIR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Vir Biotechnology Inc’s current trading price is -67.47% away from its 52-week high, while its distance from the 52-week low is -5.05%. The stock’s price range during this period has varied between$4.95 and $14.45. The Vir Biotechnology Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.55 million for the day, a figure considerably higher than their average daily volume of 1.24 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Vir Biotechnology Inc (VIR) has experienced a quarterly decline of -48.18% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 649.72M and boasts a workforce of 408 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.79, with a change in price of -2.86. Similarly, Vir Biotechnology Inc recorded 1,754,570 in trading volume during the last 100 days, posting a change of -37.83%.
VIR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VIR stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.08.
VIR Stock Stochastic Average
As of today, Vir Biotechnology Inc’s raw stochastic average for the last 50 days stands at 0.26%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 0.62%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 8.28% and 17.80%, respectively.
